Shannon Thyme Klinger Moderna, Inc. (MRNA) insider trading activity

Shannon Thyme Klinger is Chief Legal Officer of Moderna, Inc.. Currently has a direct ownership of 28,170 shares of MRNA, which is worth approximately $672,699. The most recent transaction as insider was on Dec 02, 2024, when has been sold 232 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 28.2K

2.5% 3M change

55.17% 12M change

Total Value Held $672,699

Shannon Thyme Klinger Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 02 2024	BUY Exercise of conversion of derivative security	-	232 Added 1.15%	19,949 Common Stock
Nov 29 2024	SELL Open market or private sale	$60,676 $42.79 p/Share	1,418 Reduced 6.71%	19,717 Common Stock
Nov 27 2024	BUY Exercise of conversion of derivative security	-	2,981 Added 12.36%	21,135 Common Stock
Sep 09 2024	SELL Open market or private sale	$40,537 $73.57 p/Share	551 Reduced 2.95%	18,154 Common Stock
Sep 06 2024	BUY Exercise of conversion of derivative security	-	1,139 Added 5.74%	18,705 Common Stock
Sep 03 2024	SELL Open market or private sale	$8,776 $76.99 p/Share	114 Reduced 0.64%	17,566 Common Stock
Aug 30 2024	BUY Exercise of conversion of derivative security	-	233 Added 1.3%	17,680 Common Stock
Aug 29 2024	SELL Open market or private sale	$12,640 $78.03 p/Share	162 Reduced 0.92%	17,447 Common Stock
Aug 28 2024	SELL Open market or private sale	$104,715 $79.39 p/Share	1,319 Reduced 7.09%	17,280 Common Stock
Aug 28 2024	BUY Exercise of conversion of derivative security	-	329 Added 1.83%	17,609 Common Stock
Aug 27 2024	BUY Exercise of conversion of derivative security	-	2,652 Added 12.48%	18,599 Common Stock
Jun 10 2024	SELL Open market or private sale	$766,810 $148.09 p/Share	5,178 Reduced 24.51%	15,947 Common Stock
Jun 07 2024	BUY Exercise of conversion of derivative security	-	10,247 Added 32.66%	21,125 Common Stock
Jun 03 2024	SELL Open market or private sale	$17,167 $140.72 p/Share	122 Reduced 1.11%	10,878 Common Stock
May 31 2024	BUY Exercise of conversion of derivative security	-	232 Added 2.07%	11,000 Common Stock
May 29 2024	SELL Open market or private sale	$26,443 $144.5 p/Share	183 Reduced 1.67%	10,768 Common Stock
May 28 2024	SELL Open market or private sale	$210,561 $162.47 p/Share	1,296 Reduced 10.87%	10,623 Common Stock
May 28 2024	BUY Exercise of conversion of derivative security	-	328 Added 2.91%	10,951 Common Stock
May 24 2024	BUY Exercise of conversion of derivative security	-	2,652 Added 18.2%	11,919 Common Stock
Mar 08 2024	SELL Open market or private sale	$53,883 $99.05 p/Share	544 Reduced 5.54%	9,267 Common Stock
Mar 07 2024	BUY Exercise of conversion of derivative security	-	1,138 Added 10.39%	9,811 Common Stock
Mar 04 2024	SELL Open market or private sale	$11,037 $94.34 p/Share	117 Reduced 1.33%	8,673 Common Stock
Mar 01 2024	BUY Exercise of conversion of derivative security	-	233 Added 2.58%	8,790 Common Stock
Feb 29 2024	SELL Open market or private sale	$63,361 $94.57 p/Share	670 Reduced 7.26%	8,557 Common Stock
Feb 28 2024	BUY Exercise of conversion of derivative security	-	1,315 Added 12.47%	9,227 Common Stock

Also insider at

RFL

Rafael Holdings, Inc. Real Estate

Director

STK